Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab in Recurrent Solid Tumor Brain Metastases
NCT01898130Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Nov 2013
- Primary completion
- Mar 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in brain metastases, sponsored by Northwestern University. Started Nov 2013; status: completed.
02
Drugs
bevacizumab
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT01898130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01898130.